• SENSEX 76,132.81
    -382.62 (--0.50%)
  • BANKNIFTY 57,088.30
    -281.35 (--0.49%)
  • Syrma SGS Tech.
    1,644.85 1,644.85(%)
  • IFCI
    107.30 107.45(%)
  • PC Jeweller
    14.07 15.38(%)
  • Swiggy
    280.45 473.00(%)
  • ICICI Bank
    1,433.95 1,479.90(%)
  • Milky Mist Dairy
    277.80 277.80(%)
  • MV Electrosystems
    841.00 841.00(%)
  • Kotak Mah. Bank
    421.00 345.40(%)
  • ASM Technologies
    6,275.95 6,275.95(%)
  • Bharti Airtel
    1,855.10 2,174.70(%)
  • Ather Energy
    1,617.95 1,741.90(%)
  • Pidilite Inds.
    1,585.00 1,259.45(%)
  • Netweb Technol.
    5,138.35 2,820.80(%)
  • Lalithaa Jewel
    326.75 326.75(%)
  • Cummins India
    4,987.55 3,802.55(%)
  • Gland Pharma
    3,041.95 3,041.95(%)
  • HDFC Bank
    707.25 698.50(%)
  • SBI
    1,001.00 805.40(%)
  • Multi Comm. Exc.
    3,374.15 3,479.80(%)
  • Aditya Birla Cap
    408.75 430.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Curis Lifesciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 94348.0
  • ISIN : INE1BZN01016
165.70 14 (9.48%)
  • As on 07 Sep 2026 (EOD)

  • Today’s Low

    151.35

  • Today’s High

    169.80

  • Open

    151.35

  • Perv Close

    151.35

  • 52W Low

    83.60

  • 52W High

    169.80

Key Indicators

  • P/E(TTM)

    19.33

  • Mar.Cap (₹Cr.)

    133.96

  • Div & Yield %

    0.00

  • Book Value(₹)

    58.57

  • Debt-Equity Ratio

    9.48

  • AGM Date

    07-Sep-2026

  • EPS

    8.57

  • P/E Ratio

    19.33

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    133.96

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    8.08

  • BV (₹)

    58.60

  • Sales( ₹ in Cr.)

    60.63

  • NP (in Cr.)

    6.93

  • NP Var(%)

    13.0

  • Div%

    0.0

  • CPS (₹)

    9.40

  • EPS (₹)

    8.60

  • Traded Value (₹ in Lakhs)

    122.36

  • 52 Week High

    169.80

  • 52 Week Low

    83.60

  • Price BSE

    0.0

  • Price NSE

    151.00

  • Market Capital( in Cr.)

    122.36

  • P/C Ratio

    16.00

  • P/E Ratio

    17.60

  • Price Vs.BV

    8.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar
INCOME :            
Sales Turnover 49.13 35.56 35.42 23.75 - -
Excise Duty 0.00 0.00 0.00 0.00 - -
Net Sales 49.13 35.56 35.42 23.75 - -
Other Income 0.51 0.31 0.34 0.02 - -
Stock Adjustments 2.07 0.83 0.37 0.60 - -
Total Income 51.71 36.70 36.13 24.37 - -
EXPENDITURE :            
Raw Materials 21.41 12.80 16.60 10.02 - -
Power and Fuel Cost 1.59 1.68 1.29 1.26 - -
Employee Cost 3.11 2.74 2.18 3.22 - -
Other Manufacturing Expenses 14.41 9.50 10.67 5.02 - -
Selling and Administration Expenses 0.87 1.07 1.47 0.98 - -
Miscellaneous Expenses 0.28 0.21 0.34 0.26 - -
Employee Benefit Expenses 3.11 2.74 2.18 3.22 - -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 - -
Total Expenses 41.67 28.00 32.54 20.76 - -
Operating Profit 10.05 8.70 3.60 3.60 - -
Interest 1.11 0.85 1.33 1.62 - -
Gross Profit 8.94 7.85 2.27 1.98 - -
Depreciation 0.67 0.68 0.73 0.75 - -
Profit Before Tax 8.27 7.17 1.54 1.23 - -
Current Tax 2.16 1.62 0.00 0.00 - -
Fringe Benefit tax 0.00 0.00 0.00 0.00 - -
Deferred Tax 0.01 0.69 0.31 0.73 - -
Reported Net Profit 6.11 4.87 1.23 0.49 - -
Extraordinary Items 0.00 0.00 0.01 0.00 - -
Adjusted Net Profit 6.11 4.87 1.22 0.49 - -
Adjustment below Net Profit -5.39 0.00 0.00 0.02 - -
P & L Balance brought forward 5.37 0.51 -1.40 -1.91 - -
Statutory Appropriations 0.00 0.00 0.00 0.00 - -
Appropriations 0.00 0.00 0.00 0.00 - -
P & L Balance carried down 6.08 5.37 -0.18 -1.40 - -
Dividend 0.00 0.00 0.00 0.00 - -
Preference Dividend 0.00 0.00 0.00 0.00 - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 - -
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 - -
Earnings Per Share-Unit Curr 10.29 97.34 24.52 9.85 - -
Earnings Per Share(Adj)-Unit Curr - - - - - -
Book Value 27.34 117.46 6.45 -18.07 - -
Book Value(Adj)-Unit Curr - - - - - -

Shareholding Pattern

  • Promoter Group

    68.03%

  • Public Share Holding

    31.97%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,500,000 68.03 5,500,000 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,500,000 68.03 5,500,000 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 96,000 1.19 96,000 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 469,104 5.80 469,104 7
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 565,104 6.99 565,104 10
2] Non Institution
Bodies Corporate 411,145 5.09 411,145 7
Clearing Members 279,000 3.45 279,000 5
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 6,000 0.07 6,000 5
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 155,641 1.93 155,641 33
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 484,099 5.99 484,099 13
Individuals holding nominal share capital up to Rs. 1 lakh 678,445 8.39 678,445 259
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,019,330 24.98 2,019,330 323
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 8,084,434 100.00 8,084,434 340

Company Background

Curis Lifesciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Curis Lifesciences Ltd
  • BSE Code : 94348.0
  • ISIN : INE1BZN01016

  • Incorporation Year

    2016

  • Registered Office

    PF-23 GIDC Sanand II
    Industrial Estate, Ahmedabad,
    Gujarat-382110

  • Telephone

    +91 70965 58558

  • FAX

  • Chairman

    Dharmesh Dasharathbhai Patel

  • Managing Director

  • Company Secretary

    NIKHIL PUROHIT

  • Auditor

    B T Vora & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Curis Lifesciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Curis Lifescien. 165.70 49.65 49.13 19.36 34.13
Abbott India 25,896.45 7,217.19 6,929.05 34.08 43.78
Astrazeneca Phar 6,853.70 2,304.07 2,275.58 101.01 27.86
Glaxosmi. Pharma 2,956.95 3,932.76 3,790.20 47.24 58.17
Novartis India 1,639.90 393.10 354.33 41.41 15.94
Cipla 1,395.95 20,102.60 18,979.95 36.69 13.88
Bliss GVS Pharma 696.45 773.53 729.81 64.73 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 496.40 474.15 450.25 23.17 18.77
Guj. Themis Bio. 429.65 152.47 150.80 114.88 27.21
Ambalal Sarabhai 42.42 19.52 3.94 78.56 6.77